These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8579032

  • 1. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
    Kostis JB, Shelton B, Gosselin G, Goulet C, Hood WB, Kohn RM, Kubo SH, Schron E, Weiss MB, Willis PW, Young JB, Probstfield J.
    Am Heart J; 1996 Feb; 131(2):350-5. PubMed ID: 8579032
    [Abstract] [Full Text] [Related]

  • 2. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J.
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [Abstract] [Full Text] [Related]

  • 3. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure.
    Böhm M, Pogue J, Kindermann I, Pöss J, Koon T, Yusuf S.
    Eur J Heart Fail; 2014 Mar; 16(3):325-33. PubMed ID: 24464788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
    Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC, Studies Of Left Ventricular Dysfunction.
    Circulation; 2003 Mar 11; 107(9):1291-6. PubMed ID: 12628950
    [Abstract] [Full Text] [Related]

  • 6. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
    Jong P, Yusuf S, Rousseau MF, Ahn SA, Bangdiwala SI.
    Lancet; 2003 May 31; 361(9372):1843-8. PubMed ID: 12788569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tolerability of enalapril in congestive heart failure.
    Warner NJ, Rush JE, Keegan ME.
    Am J Cardiol; 1989 Feb 21; 63(8):33D-37D. PubMed ID: 2537564
    [Abstract] [Full Text] [Related]

  • 9. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1992 Aug 21; 86(2):431-8. PubMed ID: 1638712
    [Abstract] [Full Text] [Related]

  • 10. Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance.
    Bart BA.
    Am Heart J; 1999 Nov 21; 138(5 Pt 1):801-3. PubMed ID: 10539807
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D.
    Circulation; 1993 Nov 21; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [Abstract] [Full Text] [Related]

  • 12. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB, Yusuf S, Naylor CD.
    Am Heart J; 2002 Dec 21; 144(6):941-7. PubMed ID: 12486418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.
    Exner DV, Dries DL, Domanski MJ, Cohn JN.
    N Engl J Med; 2001 May 03; 344(18):1351-7. PubMed ID: 11333991
    [Abstract] [Full Text] [Related]

  • 15. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.
    Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C, Shelton B.
    Circulation; 1995 May 15; 91(10):2573-81. PubMed ID: 7743619
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.
    Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA.
    J Am Coll Cardiol; 1998 Feb 15; 31(2):419-25. PubMed ID: 9462588
    [Abstract] [Full Text] [Related]

  • 17. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
    Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A.
    Circulation; 2003 Jun 17; 107(23):2926-31. PubMed ID: 12771010
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
    Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA.
    J Am Coll Cardiol; 2005 Feb 01; 45(3):391-9. PubMed ID: 15680718
    [Abstract] [Full Text] [Related]

  • 19. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
    Capes SE, Gerstein HC, Negassa A, Yusuf S.
    Diabetes Care; 2000 Mar 01; 23(3):377-80. PubMed ID: 10868869
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A, Venkatesan S, Subramaniam T, Jagannathan V, Elangovan S, Alagesan R, Gnanavelu G, Dorairajan S, Krishna BP, Chockalingam V, Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis.
    Am Heart J; 2004 Apr 01; 147(4):E19. PubMed ID: 15077102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.